{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T20:35:16Z","timestamp":1777581316056,"version":"3.51.4"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T00:00:00Z","timestamp":1689379200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008486","name":"Schweizerische Multiple Sklerose Gesellschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008486","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009068","name":"University of Bern","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009068","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.msard.2023.104892","type":"journal-article","created":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T04:28:40Z","timestamp":1689568120000},"page":"104892","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Modelling MOG antibody-associated disorder and neuromyelitis optica spectrum disorder in animal models: Spinal cord manifestations"],"prefix":"10.1016","volume":"78","author":[{"given":"Jana","family":"Remlinger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maud","family":"Bagnoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivo","family":"Meli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marine","family":"Massy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Linington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey L.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Hoepner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volker","family":"Enzmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4751-299X","authenticated-orcid":false,"given":"Anke","family":"Salmen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2023.104892_bib0001","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.1400401","article-title":"Neutrophils mediate blood\u2013spinal cord barrier disruption in demyelinating neuroinflammatory diseases","author":"Aub\u00e9","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.msard.2023.104892_bib0002","doi-asserted-by":"crossref","DOI":"10.3390\/cells9102154","article-title":"Hoepner R. c-Jun N-terminal kinase as a therapeutic target in experimental autoimmune encephalomyelitis","volume":"9","author":"Bagnoud","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.msard.2023.104892_bib0003","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/ana.21802","article-title":"Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica","volume":"66","author":"Bennett","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2023.104892_bib0004","first-page":"355","article-title":"Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system","volume":"76","author":"Berger","year":"1997","journal-title":"Lab. Invest."},{"key":"10.1016\/j.msard.2023.104892_bib0005","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/B978-0-444-63432-0.00008-6","article-title":"Neurologic autoimmunity: mechanisms revealed by animal models","volume":"133","author":"Bradl","year":"2016","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.msard.2023.104892_bib0006","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/ana.21837","article-title":"Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo","volume":"66","author":"Bradl","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2023.104892_bib0007","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/ana.21916","article-title":"Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease","volume":"66","author":"Brilot","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2023.104892_bib0008","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0165-5728(98)00243-4","article-title":"Cloning the antibody response in humans with inflammatory CNS disease: isolation of measles virus-specific antibodies from phage display libraries of a subacute sclerosing panencephalitis brain","volume":"94","author":"Burgoon","year":"1999","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2023.104892_bib0009","doi-asserted-by":"crossref","first-page":"655","DOI":"10.4161\/mabs.25439","article-title":"Autoantibody depletion ameliorates disease in murine experimental autoimmune encephalomyelitis","volume":"5","author":"Challa","year":"2013","journal-title":"MAbs"},{"key":"10.1016\/j.msard.2023.104892_bib0010","first-page":"4025","article-title":"Astrocyte-microglia interaction drives evolving neuromyelitis optica lesion","volume":"130","author":"Chen","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.msard.2023.104892_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-019-0766-7","article-title":"Complement-independent bystander injury in AQP4-IgG seropositive neuromyelitis optica produced by antibody-dependent cellular cytotoxicity","volume":"7","author":"Duan","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.msard.2023.104892_bib0012","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/bpa.12793","article-title":"Experimental animal models of aquaporin-4-IgG-seropositive neuromyelitis optica spectrum disorders: progress and shortcomings","volume":"30","author":"Duan","year":"2020","journal-title":"Brain Pathol."},{"key":"10.1016\/j.msard.2023.104892_bib0013","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.1073\/pnas.1701960114","article-title":"Autoantibody-induced internalization of CNS AQP4 water channel and EAAT2 glutamate transporter requires astrocytic Fc receptor","volume":"114","author":"Hinson","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.msard.2023.104892_bib0014","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00401-020-02132-y","article-title":"The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody","volume":"139","author":"H\u00f6ftberger","year":"2020","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.msard.2023.104892_bib0015","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12974-018-1144-2","article-title":"MOG encephalomyelitis: international recommendations on diagnosis and antibody testing","volume":"15","author":"Jarius","year":"2018","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.msard.2023.104892_bib0016","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/jnnp-2016-314005","article-title":"Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease","volume":"88","author":"Jury\u0144czyk","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2023.104892_bib0017","doi-asserted-by":"crossref","first-page":"e16083","DOI":"10.1371\/journal.pone.0016083","article-title":"Functional characterization of aquaporin-4 specific T cells: towards a model for neuromyelitis optica","volume":"6","author":"Kalluri","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.msard.2023.104892_bib0018","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.bbrc.2009.06.085","article-title":"Neuromyelitis optica: passive transfer to rats by human immunoglobulin","volume":"386","author":"Kinoshita","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.msard.2023.104892_bib0019","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/BF00686201","article-title":"Experimental allergic encephalomyelitis: the balance between encephalitogenic T lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions","volume":"75","author":"Lassmann","year":"1988","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.msard.2023.104892_bib0020","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"Lennon","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.msard.2023.104892_bib0021","first-page":"443","article-title":"Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin\/oligodendrocyte glycoprotein","volume":"130","author":"Linington","year":"1988","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.msard.2023.104892_bib0022","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/nm0602-620","article-title":"CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation","volume":"8","author":"Linker","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.msard.2023.104892_bib0023","doi-asserted-by":"crossref","first-page":"e1316","DOI":"10.1002\/cti2.1316","article-title":"Pathogenesis of autoimmune demyelination: from multiple sclerosis to neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody-associated disease","volume":"10","author":"Lopez","year":"2021","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.msard.2023.104892_bib0024","doi-asserted-by":"crossref","first-page":"eabe9726","DOI":"10.1126\/scitranslmed.abe9726","article-title":"In utero exposure to maternal anti-aquaporin-4 antibodies alters brain vasculature and neural dynamics in male mouse offspring","volume":"14","author":"Mader","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.msard.2023.104892_bib0025","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1093\/brain\/awl135","article-title":"A new focal EAE model of cortical demyelination: multiple sclerosis-like lesions with rapid resolution of inflammation and extensive remyelination","volume":"129","author":"Merkler","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.msard.2023.104892_bib0026","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12974-017-0984-5","article-title":"Human antibodies against the myelin oligodendrocyte glycoprotein can cause complement-dependent demyelination","volume":"14","author":"Peschl","year":"2017","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.msard.2023.104892_bib0027","doi-asserted-by":"crossref","first-page":"13829","DOI":"10.1074\/jbc.M112.344325","article-title":"Complement-dependent cytotoxicity in neuromyelitis optica requires aquaporin-4 protein assembly in orthogonal arrays","volume":"287","author":"Phuan","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.msard.2023.104892_bib0028","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2249.1991.tb05622.x","article-title":"Antibody-mediated demyelination in experimental allergic encephalomyelitis is independent of complement membrane attack complex formation","volume":"83","author":"Piddlesden","year":"1991","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.msard.2023.104892_bib0029","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1212\/WNL.0000000000001126","article-title":"Diagnostic utility of aquaporin-4 in the analysis of active demyelinating lesions","volume":"84","author":"Popescu","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2023.104892_bib0030","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00401-013-1172-z","article-title":"Involvement of antibody-dependent cell-mediated cytotoxicity in inflammatory demyelination in a mouse model of neuromyelitis optica","volume":"126","author":"Ratelade","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.msard.2023.104892_bib0031","doi-asserted-by":"crossref","first-page":"e27412","DOI":"10.1371\/journal.pone.0027412","article-title":"Intravenous neuromyelitis optica autoantibody in mice targets aquaporin-4 in peripheral organs and area postrema","volume":"6","author":"Ratelade","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.msard.2023.104892_bib0032","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.molimm.2014.06.003","article-title":"Inhibitor(s) of the classical complement pathway in mouse serum limit the utility of mice as experimental models of neuromyelitis optica","volume":"62","author":"Ratelade","year":"2014","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.msard.2023.104892_bib0033","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00401-012-0986-4","article-title":"Neuromyelitis optica IgG and natural killer cells produce NMO lesions in mice without myelin loss","volume":"123","author":"Ratelade","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.msard.2023.104892_bib0034","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001134","article-title":"Antineonatal Fc receptor antibody treatment ameliorates MOG-IgG-associated experimental autoimmune encephalomyelitis","volume":"9","author":"Remlinger","year":"2022","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2023.104892_bib0035","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/ana.22686","article-title":"Neutrophil protease inhibition reduces neuromyelitis optica-immunoglobulin G-induced damage in mouse brain","volume":"71","author":"Saadoun","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2023.104892_bib0036","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/2051-5960-2-35","article-title":"Neuromyelitis optica MOG-IgG causes reversible lesions in mouse brain","volume":"2","author":"Saadoun","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.msard.2023.104892_bib0037","doi-asserted-by":"crossref","DOI":"10.3791\/56185","article-title":"Induction of paralysis and visual system injury in mice by T cells specific for neuromyelitis optica autoantigen aquaporin-4","author":"Sagan","year":"2017","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.msard.2023.104892_bib0038","doi-asserted-by":"crossref","first-page":"14781","DOI":"10.1073\/pnas.1617859114","article-title":"Tolerance checkpoint bypass permits emergence of pathogenic T cells to neuromyelitis optica autoantigen aquaporin-4","volume":"113","author":"Sagan","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.msard.2023.104892_bib0039","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1471-2377-13-104","article-title":"Passively transferred human NMO-IgG exacerbates demyelination in mouse experimental autoimmune encephalomyelitis","volume":"13","author":"Saini","year":"2013","journal-title":"BMC Neurol."},{"key":"10.1016\/j.msard.2023.104892_bib0040","doi-asserted-by":"crossref","first-page":"eaai9111","DOI":"10.1126\/scitranslmed.aai9111","article-title":"Glucose-regulated protein 78 autoantibody associates with blood-brain barrier disruption in neuromyelitis optica","volume":"9","author":"Shimizu","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.msard.2023.104892_bib0041","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1172\/JCI122942","article-title":"Membrane assembly of aquaporin-4 autoantibodies regulates classical complement activation in neuromyelitis optica","volume":"129","author":"Soltys","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.msard.2023.104892_bib0042","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.molimm.2014.06.010","article-title":"How antibodies use complement to regulate antibody responses","volume":"61","author":"S\u00f6rman","year":"2014","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.msard.2023.104892_bib0043","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1212\/NXI.0000000000000257","article-title":"Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis","volume":"3","author":"Spadaro","year":"2016","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2023.104892_bib0044","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/ana.25291","article-title":"Pathogenicity of human antibodies against myelin oligodendrocyte glycoprotein","volume":"84","author":"Spadaro","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2023.104892_bib0045","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3390\/vaccines9060660","article-title":"Development of a macrophage-based ADCC assay","volume":"9","author":"Uccellini","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.msard.2023.104892_bib0046","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.4049\/jimmunol.181.8.5730","article-title":"Functional consequences of neuromyelitis optica-IgG astrocyte interactions on blood-brain barrier permeability and granulocyte recruitment","volume":"181","author":"Vincent","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.msard.2023.104892_bib0047","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"Weinshenker BG. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2023.104892_bib0048","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.neuroscience.2008.07.037","article-title":"Glial reactions and degeneration of myelinated processes in spinal cord gray matter in chronic experimental autoimmune encephalomyelitis","volume":"156","author":"Wu","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.msard.2023.104892_bib0049","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1212\/NXI.0000000000000062","article-title":"Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder?","volume":"2","author":"Zamvil","year":"2015","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034823003930?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034823003930?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:13:42Z","timestamp":1761902022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034823003930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":49,"alternative-id":["S2211034823003930"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2023.104892","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modelling MOG antibody-associated disorder and neuromyelitis optica spectrum disorder in animal models: Spinal cord manifestations","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2023.104892","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104892"}}